Alcohol-induced facial erythema in patients treated with dupilumab: a case series and systematic review
Clinical and Experimental Dermatology · 2025
DOI: 10.1093/ced/llaf206 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Amit Iton-Schwartz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Rabin Medical Center, Petah Tikva, Israel. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Erythema, Dermatitis, Atopic, Facial Dermatoses. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Background
Dupilumab-associated head and neck dermatitis in patients with atopic dermatitis has been extensively documented. A distinctive short-lived facial erythema after alcohol ingestion in patients treated with dupilumab has recently emerged.
Objectives
To characterize alcohol-induced facial erythema on treatment with dupilumab.
Methods
We conducted a systematic review based on PubMed and Google Scholar searches for publications on alcohol-induced facial erythema on treatment with dupilumab. A case series from our centre was added to this review. Data were summarized using descriptive statistics and a narrative review. This systematic review adhered to PRISMA reporting guidelines and was registered with PROSPERO (CRD42024571723).
Results
Seven publications describing nine patients and five more from our case series were included. All were adults treated for atopic dermatitis (nine males; mean age 32.4 years, SD 9.8). Six patients applied concomitant topical calcineurin inhibitors. At a median of 26 weeks (range 3 weeks to 3 years) from dupilumab initiation, patients exhibited facial erythema/flushing within minutes of alcohol consumption, resolving spontaneously in an hour. No patient discontinued dupilumab. One patient reported initial successful prophylaxis with a histamine H2-receptor antagonist.
Conclusions
Alcohol-induced facial erythema/flushing on dupilumab has only been described in atopic dermatitis and is characterized by an acute onset and rapid resolution. Topical calcineurin inhibitor applications did not account for most patients’ cases. Although seemingly an uncommon phenomenon, its social media presence suggests that it is underreported and troublesome to patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Dermatology, Rabin Medical Center, Petah Tikva, Israel.
- Pediatric Dermatology Unit, Schneider Children's Medical Center, Petah Tikva, Israel.
- Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
ORCID-Profile: Amit Iton-Schwartz, Yael A Leshem
Zitieren
APA
Iton-Schwartz, A., Friedland, R., Mimouni, D., & Leshem, Y. A. (2025). Alcohol-induced facial erythema in patients treated with dupilumab: a case series and systematic review. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf206
Vancouver
Iton-Schwartz A, Friedland R, Mimouni D, Leshem YA. Alcohol-induced facial erythema in patients treated with dupilumab: a case series and systematic review. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf206
BibTeX
@article{ItonSchwartz2025,
author = {Iton-Schwartz, Amit and Friedland, Rivka and Mimouni, Daniel and Leshem, Yael A},
title = {Alcohol-induced facial erythema in patients treated with dupilumab: a case series and systematic review},
journal = {Clinical and Experimental Dermatology},
year = {2025},
doi = {10.1093/ced/llaf206}
}
EUVIMED